跳至主要内容
临床试验/PACTR201707002355147
PACTR201707002355147招募中未知

Efficacy of Intra-Tympanic Dexamethasone on prevention of Ototoxicity in patients on Cisplatin therapy

COLLEGE OF MEDICINE0 个研究点目标入组 0 人开始时间: 2017年6月14日最近更新:
适应症

试验速览

阶段
未知
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Year(s) 至 90 Year(s)(—)
性别
All

入选标准

  • Patients with solid cancers on cisplatin based chemotherapy

排除标准

  • 1. Severely ill patients who cannot undergo the hearing examination.
  • 2. Pathological findings on otoscopy that do not allow safe ITD delivery
  • 3. Previous inner ear disease with resultant sensorineural hearing loss
  • 4. Conductive hearing loss >5 dBHL
  • 5. Pure tone thresholds average (PTA) >40 dBHL for the frequencies 500 to 3000 Hz or 4000 to 8000 Hz16
  • 6. Asymmetry of PTA between the ears >10 dBHL for the frequencies 500 to 3000 Hz or 4000 to 8000 Hz16
  • 7. Previous treatment with Cisplatin
  • 8. History of radiation therapy (or planned concurrent radiation therapy) to the head and neck regions.

研究者

相似试验